Primary antifungal prophylaxis in leukaemia patients

descriptionPublicationkeyboard_double_arrow_right Article 01 Jul 2007 English Publisher:Elsevier BVJournal:European Journal of Cancer Supplements, volume 5, pages 43-48 (issn: 1359-6349,

Copyright policy )

Authors: Johan A. Maertens; Pascale Frère; Cornelia Lass-Flörl; Werner Heinz; Oliver A. Cornely;

doi: 10.1016/j.ejcsup.2007.06.006

Primary antifungal prophylaxis in leukaemia patients

- Summary
- Metrics

Abstract

These recommendations have been developed by an expert panel following an evidencebased search of the literature assessing the role of primary antifungal prophylaxis in patients with acute leukaemia or stem cell transplantation. We present results from a questionnaire on the current practice among experts in Europe, show results of the literature search and provide the panel’s recommendations.

Related Organizations

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	52
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%